Form 4 for OM Outset Medical, Inc.
Accepted 2023-11-17 00:00:00 ET · period of report 2023-11-16 · accession 0001484612-23-000089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-17 | 2023-11-16 | OM | Racine Jean-Olivier | CTO | S - Sale | $4.76 | -790 | 77.7K | -1% | -$3,760 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-16 | S | D | 790 | $4.76 | 77,686 | D | — | — | (F1) Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 2,971 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021 and January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. (F2) Includes 1 share of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2023 to August 31, 2023. This transaction is exempt from Rule 16b-3(c). |